Minimizing inappropriate medications in older populations: A 10-step conceptual framework

American Journal of Medicine

Volumn 125, Issue 6, 2012, Pages

  Scott, Ian A ^a   Gray, Leonard C ^a   Martin, Jennifer H ^a   Mitchell, Charles A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Inappropriate use; Medication; Minimization framework; Older populations

Indexed keywords

ANTIDIABETIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPNOTIC AGENT; INSULIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; VASODILATOR AGENT;

COGNITIVE DEFECT; CONCEPTUAL FRAMEWORK; DECISION MAKING; DRUG THERAPY; HEART FAILURE; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; LIFE EXPECTANCY; LIVER DISEASE; MEDICATION THERAPY MANAGEMENT; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUALITY OF LIFE; REVIEW; SURVIVAL; VALIDATION PROCESS;

EID: 84862777885     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.09.021     Document Type: Review

References (79)

1. Slone Epidemiology Center Patterns of medication use in the United States, 2006: a report from the Slone survey http://www.bu.edu/slone/ SloneSurvey/AnnualRpt/SloneSurveyWebReport2006.pdf Accessed January 6, 2010
2. L. Mallet, A. Spinewine, A. Huang The challenge of managing drug interactions in elderly people Lancet 370 2007 185 191
3. J.T. Hanlon, K.E. Schmader, M.J. Koronkowski Adverse drug events in high risk older outpatients J Am Geriatr Soc 45 1997 945 948
4. H.J.M. Beijer, C.J. de Blaey Hospitalisations caused by adverse drug reactions (ADRs): a meta-analysis of observational studies Pharm World Sci 24 2002 46 54
5. J. Doucet, A. Jego, D. Noel Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly A prospective study Clin Drug Invest 22 2002 385 392
6. A.J. Leendertse, A.C. Egberts, L.J. Stoker, P.M. van den Bemt PHARM Study Group Frequency of and risk factors for preventable medication-related hospital admission in the Netherlands Arch Intern Med 168 2008 1890 1896
7. D.M. Fick, J.W. Cooper, W.E. Wade, J.L. Waller, J.R. Maclean, M.H. Beers Updating the Beers criteria for potentially inappropriate medication use in older adults Results of a US consensus panel of experts Arch Intern Med 163 2003 2716 2724
8. S.M. Willcox, D.U. Himmelstein, S. Woolhandler Inappropriate drug prescribing for the community-dwelling elderly JAMA 272 1994 292 296
9. P.F. Gallagher, P.J. Barry, C. Ryan, I. Hartigan, D. O'Mahony Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria Age Ageing 37 2008 96 101
10. E. Somers, D. Simmonds, C. Whitelaw, J. Calver, C. Beer Quality use of medicines in residential aged care Aust Fam Phys 39 2010 413 416
11. R.M. Goldberg, J. Mabee, L. Chan, S. Wong Drug-drug and drug-disease interactions in the emergency department: analysis of a high risk population Am J Emerg Med 14 1996 447 450
12. G. Onder, M. Petrovic, B. Tangiisuran Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older The gerontoNet adverse drug reactions risk score Arch Intern Med 170 2010 1142 1148
13. S.N. Hilmer, D. Gnjidic The effects of polypharmacy in older adults Clin Pharmacol Ther 85 2009 86 88
14. C.M. Boyd, J. Darer, C. Boult Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases Implications for pay for performance JAMA 294 2005 716 724
15. I.A. Scott, G.H. Guyatt Cautionary tales in the interpretation of clinical studies involving older persons Arch Intern Med 170 2010 587 595
16. N.S. Beckett, R. Peters, A.E. Fletcher Treatment of hypertension in patients 80 years of age and older N Engl J Med 358 2008 1887 1898
17. V.M. Musini, A.M. Tejani, K. Bassett, J.M. Wright Pharmacotherapy for hypertension in the elderly Cochrane Database Syst Rev 7 4 2009 CD000028
18. S.P. Fitzgerald, G. Phillipov Patient attitudes to commonly promoted medical interventions Med J Aust 172 2000 9 12
19. B.G. Fincke, D.R. Miller, A. Spiro The interaction of patient perception of overmedication with drug compliance and side effects J Gen Intern Med 13 1998 182 185
20. T.R. Fried, M.E. Tinetti, V. Towle, J.R. O'Leary, L. Iannone Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention Arch Intern Med 171 2011 923 928
21. G. Elwyn, A. Edwards, M. Eccles, D. Rovner Decision analysis in patient care Lancet 358 2001 571 574
22. T.R. Fried, M.E. Tinetti, L. Iannone Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions Arch Intern Med 171 2011 75 80
23. L. Fraenkel, T.R. Fried Individualised medical decision making: necessary, achievable, but not yet attainable Arch Intern Med 170 2010 566 569
24. M. Pollock, O.V. Bazaldua, A. Dobbie Appropriate prescribing of medications: an eight-step approach Am Fam Physician 75 2007 231 236
25. M.A. Steinman, J.T. Hanlon Managing medications in clinically complex elders "There's got to be a happy medium" JAMA 304 2010 1592 1601
26. I. Bayoumi, M. Howard, A.M. Holbrook, I. Schabort Interventions to improve medication reconciliation in primary care Ann Pharmacother 43 2009 1667 1675
27. I. Klarin, A. Wimo, J. Fastbom The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old JAMA 293 2005 2131 2140
28. T.S. Field, J.H. Gurwitz, J. Avom Risk factors for adverse drug events among nursing home residents Arch Intern Med 161 2001 1629 1634
29. R.S. Evans, J.F. Lloyd, G.J. Stoddard, J.R. Nebeker, M.H. Samore Risk factors for adverse drug events: a 10 years analysis Ann Pharmacother 39 2005 1161 1168
30. H.G. Welch, P.C. Albertsen, R.F. Nease Estimating treatment benefits for the elderly: the effect of competing risks Ann Intern Med 124 1996 577 584
31. S.J. Lee, K. Lindquist, M.R. Segal, K.E. Covinsky Development and validation of a prognostic index for 4-year mortality in older adults JAMA 295 2006 801 808
32. E.C. Carey, K.E. Covinsky, L.Y. Lui, C. Eng, L.P. Sands, L.C. Walter Prediction of mortality in community-living frail elderly people with long term care needs J Am Geriatr Soc 56 2008 68 75
33. B.C. Huyhn, A. Rovner, M.W. Rich Identification of older patients with heart failure who may be candidates for hospice care: development of a simple four-item risk score J Am Geriatr Soc 56 2008 1111 1115
34. W.C. Levy, D. Mozaffarian, D.T. Linker The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
35. H.M. Krumholz, J. Chen, Y.T. Chen, Y. Wang, M.J. Radford Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project J Am Coll Cardiol 38 2001 453 459
36. C.L. Lewis, C.G. Moore, C.E. Golin, J. Griffith, A. Tytell-Brenner, M.P. Pignone Resident physicians' life expectancy estimates and colon cancer screening recommendations in elderly patients Med Decis Making 28 2008 254 261
37. L.C. Min, N.S. Wenger, D.B. Reuben, D. Saliba A short functional survey is responsive to changes in functional status among vulnerable elders J Am Geriatr Soc 56 2008 1932 1936
38. L. Gray, R. Bernabei, K. Berg Standardizing assessment of the elderly in acute care: the interRAI Acute Care instrument J Am Geriatr Soc 56 2008 536 541
39. C. May, V.M. Montori, F.S. Mair We need minimally disruptive medicine BMJ 339 2009 b2803
40. A. Owen, S. Cox Diagnosis of heart failure in elderly patients in primary care Eur J Heart Fail 3 2001 79 81
41. J. Meara, B.K. Bhowmick, P. Hobson Accuracy of diagnosis in patients with presumed Parkinson's disease Age Ageing 28 1999 99 102
42. G.A. Schmidt, K.E. Horner, D.L. McDanel, M.B. Ross, K.G. Moores Risks and benefits of long-term bisphosphonate therapy Am J Health Syst Pharm 67 2010 994 1001
43. H.K. Berthold, I. Gouni-Berthold Lipid-lowering drug therapy in elderly patients Curr Pharm Des 17 2011 877 893
44. J.R. Curtis, A.O. Westfall, H. Cheng, K. Lyles, K.G. Saag, E. Delzell Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users J Bone Miner Res 23 2008 1435 1441
45. S.R. Cummings, D.M. Black, D.E. Thompson Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures JAMA 280 1998 2077 2082
46. M.R. McClung, P. Geusens, P.D. Miller Hip Intervention Program Study Group Effect of risedronate on the risk of hip fracture in elderly women Hip Intervention Program Study Group N Engl J Med 344 2001 333 340
47. A. Ungar, G. Pepe, L. Lambertucci Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension J Am Geriatr Soc 57 2009 291 296
48. B. Bouillet, G. Vaillant, J.M. Petit Are elderly patients with diabetes being overtreated in French long-term-care homes? Diabetes Metab 36 2010 272 277
49. E. Huang, N. Gandra, Q. Zhang, M. Chin, D. Meltzer The impact of functional status and comorbid illness on the expected benefits of intensive glucose control in older diabetic patients J Am Geriatr Soc 55 2007 S213 S214
50. S. Rietbrock, E. Heeley, J. Plumb, T. van Staa Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme Am Heart J 156 2008 57 64
51. G.Y.H. Lip, L. Frison, J.L. Halperin, D.A. Lane Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score J Am Coll Cardiol 57 2011 173 180
52. J.A. Kanis, E.V. McCloskey, H. Johansson, O. Strom, F. Borgstrom, A. Oden National Osteoporosis Guideline Group Case finding for the management of osteoporosis with FRAX - assessment and intervention thresholds for the UK Osteoporos Int 19 2008 1395 1408
53. J. Hippisley-Cox, C. Coupland, J. Robson, P. Brindle Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database BMJ 341 2010 c6624
54. A. Briggs, M. Spencer, H. Wang, D. Mannino, D.D. Sin Development and validation of a prognostic index for healthy outcomes in chronic obstructive pulmonary disease Arch Intern Med 168 2008 71 79
55. H. Hamilton, P. Gallagher, C. Ryan, S. Byrne, D. O'Mahony Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients Arch Intern Med 171 2011 1013 1019
56. P.F. Gallagher, M.N. O'Connor, D. O'Mahony Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START Criteria Clin Pharmacol Ther 89 2011 845 854
57. P.J. Barry, N. O'Keefe, K.A. O'Connor, D. O'Mahony Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalised patients J Clin Pharm Ther 31 2006 617 626
58. M. Wehling Multimorbidity and polypharmacy: How to reduce the classification: fit for the aged J Am Geriatric Soc 57 2009 560 561
59. R.C. Hamdy, S.W. Moore, K. Whalen Reducing polypharmacy in extended care South Med J 88 1995 534 538
60. P.G.A.M. De Smet, W. Denneboom, C. Kramers, R. Grol A composite screening tool for medication reviews of outpatients General issues with specific examples Drugs Aging 24 2007 733 760
61. D. Garfinkel, D. Mangin Feasibility study of a systematic approach for discontinuation of multiple medications in older patients Addressing polypharmacy Arch Intern Med 170 2010 1648 1654
62. S.A. Al-Rashed, D.J. Wright, N. Roebuck, H. Chrystyn The value of inpatient pharmaceutical counselling to elderly patients prior to discharge Br J Clin Pharmacol 54 2002 657 664
63. N.K. Choudry, M.A. Fischer, J. Avorn The implications of therapeutic complexity on adherence to cardiovascular medications Arch Intern Med 171 2011 814 822
64. C.H. Braddock, K.A. Edwards, N.M. Hasenberg Informed decision making in outpatient practice Time to get back to basics JAMA 282 1999 2313 2320
65. S. Iyer, V. Naganathan, A.J. McLachlan, D.G. Le Couteur Medication withdrawal trials in people aged 65 years and older A systematic review Drugs Aging 25 2008 1021 1031
66. T. Graves, J.T. Hanlon, K.E. Schmader Adverse events after discontinuing medications in elderly outpatients Arch Intern Med 157 1997 2205 2210
67. M.R. Nelson, C.M. Reid, H. Krum, T. Muir, P. Ryan, J.J. McNeil Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national drug pressure study cohort BMJ 325 2002 815
68. D.M. Black, A.V. Schwartz, K.E. Ensrud Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A randomized trial JAMA 296 2006 2927 2938
69. C. Ballard, M.L. Hanney, M. Theodoulou The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial Lancet Neurol 8 2009 151 157
70. N. van der Velde, B.H. Stricker, H.A.P. Pols, T.J.M. van der Cammen Risks of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study Br J Clin Pharmacol 63 2006 232 237
71. J. George, R.A. Elliott, D.C. Stewart A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications Drugs Aging 25 2008 307 324
72. I. Scott, C. Mitchell, L. Gray, J. Martin Optimising drug use in elderly populations - pilot study of a drug minimization guide Intern Med J 41 Suppl 2 2011 14
73. M.A. Steinman, C.S. Landefeld, G.E. Rosenthal Polypharmacy and prescribing quality in older people J Am Geriatr Soc 54 2006 1516 1523
74. A.J. Muir, L.L. Sanders, W.E. Wilkinson, K. Schmader Reducing medication regimen complexity A controlled trial J Gen Intern Med 16 2001 77 82
75. B.J. Zarowitz, L.A. Stebelsky, B.K. Muma Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting Pharmacotherapy 25 2005 1636 1645
76. K.E. Schmader, J.T. Hanlon, C.F. Pieper Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly Am J Med 116 2004 394 401
77. Medicare Australia Formula for calculating PIP payments http://www.medicareaustralia.gov.au/providers/incentives-allowances/pip/ calculating-payments.shtml Accessed July 13, 2011
78. S.I. Benrimoj, A.S. Roberts Providing patient care in community pharmacies in Australia Ann Pharmacother 39 2005 1911 1917
79. N. Nkansah, O. Mostovetsky, C. Yu Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns Cochrane Database Syst Rev 7 2010 CD000336